Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Riley

Showing results (921-930 of 959) with videos related to

Pageof 96
Sort By:
Journal of the National Cancer Institute|July 13, 2021
Development and Validation of a Risk Prediction Model for Second Primary Lung CancerEunji Choi, Nilotpal Sanyal, Victoria Y Ding, et al.
BMJ Supportive & Palliative Care|September 27, 2022
Palliative care phenotypes among critically ill patients and family members: intensive care unit prospective cohort studyChristopher E Cox, Maren K Olsen, Alice Parish, et al.
Plos One|August 24, 2016
How Can the Health System Retain Women in HIV Treatment for a Lifetime? A Discrete Choice Experiment in Ethiopia and MozambiqueMargaret E Kruk, Patricia L Riley, Anton M Palma, et al.
Annals of Family Medicine|May 13, 2009
Cumulative incidence of false-positive results in repeated, multimodal cancer screeningJennifer Miller Croswell, Barnett S Kramer, Aimee R Kreimer, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy targetZhiwei Ang, Annette Castro, Luca Paruzzo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2026
Clinical Trial Results Provide the Rationale to Protect Dual HIV-specific T Cells with a Signaling-Defective HIV Fusion InhibitorPablo Tebas, Julie K Jadlowsky, Yuqi Zhou, et al.
Nature Biotechnology|July 1, 2008
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleasesElena E Perez, Jianbin Wang, Jeffrey C Miller, et al.
The New England Journal of Medicine|May 23, 2012
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopyRobert E Schoen, Paul F Pinsky, Joel L Weissfeld, et al.
The New England Journal of Medicine|March 20, 2009
Mortality results from a randomized prostate-cancer screening trialGerald L Andriole, E David Crawford, Robert L Grubb, et al.
Journal of the National Cancer Institute|January 10, 2012
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-upGerald L Andriole, E David Crawford, Robert L Grubb, et al.
Pageof 96

Showing results (921-930 of 959) with videos related to

Sort By:
Pageof 96
Journal of the National Cancer Institute|July 13, 2021
Development and Validation of a Risk Prediction Model for Second Primary Lung CancerEunji Choi, Nilotpal Sanyal, Victoria Y Ding, et al.
BMJ Supportive & Palliative Care|September 27, 2022
Palliative care phenotypes among critically ill patients and family members: intensive care unit prospective cohort studyChristopher E Cox, Maren K Olsen, Alice Parish, et al.
Plos One|August 24, 2016
How Can the Health System Retain Women in HIV Treatment for a Lifetime? A Discrete Choice Experiment in Ethiopia and MozambiqueMargaret E Kruk, Patricia L Riley, Anton M Palma, et al.
Annals of Family Medicine|May 13, 2009
Cumulative incidence of false-positive results in repeated, multimodal cancer screeningJennifer Miller Croswell, Barnett S Kramer, Aimee R Kreimer, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy targetZhiwei Ang, Annette Castro, Luca Paruzzo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2026
Clinical Trial Results Provide the Rationale to Protect Dual HIV-specific T Cells with a Signaling-Defective HIV Fusion InhibitorPablo Tebas, Julie K Jadlowsky, Yuqi Zhou, et al.
Nature Biotechnology|July 1, 2008
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleasesElena E Perez, Jianbin Wang, Jeffrey C Miller, et al.
The New England Journal of Medicine|May 23, 2012
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopyRobert E Schoen, Paul F Pinsky, Joel L Weissfeld, et al.
The New England Journal of Medicine|March 20, 2009
Mortality results from a randomized prostate-cancer screening trialGerald L Andriole, E David Crawford, Robert L Grubb, et al.
Journal of the National Cancer Institute|January 10, 2012
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-upGerald L Andriole, E David Crawford, Robert L Grubb, et al.
Pageof 96